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Abstract. We evaluated suspected hepatic lesions 
in 30 patients using bo th  nonga ted  spin-echo mag-  
netic resonance imaging (MRI)  on a 0.35 T super- 
conduct ing  magne t  and contras t -enhanced dynam-  
ic incremental  computed  t o m o g r a p h y  (CT). In the 
27 patients with focal lesions, bo th  modalities de- 
tected abnormali t ies in 26 patients. Liver lesions 
were equally well demonst ra ted  using M R I  and 
CT in 15 patients, better demonst ra ted  by CT in 
11 patients, and better demonst ra ted  by M R I  in 
1 patient. Small lesions ( <  2 cm) were much  better 
demonst ra ted  using CT than M R I ;  this was signifi- 
cant  when knowledge of  the precise extent o f  dis- 
ease was necessary for planning surgical therapy 
or for evaluating response to chemotherapy.  Five 
patients had  significant extrahepatic  disease de- 
tected by CT;  M R I  identified extrahepatic abnor-  
malities in only 2 o f  these 5 patients. We conclude 
that  at the current  time CT is more  useful than 
nonga ted  spin-echo M R I  in the evaluat ion o f  sus- 
pected hepatic masses. 
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Magnet ic  resonance imaging (MRI)  o f  the liver 
has already demons t ra ted  considerable promise in 
the evaluat ion o f  suspected lesions [1-7]. However ,  
very few studies available compare  M R I  with ex- 
isting modalities using state-of-the-art  equipment  
and technique. In  this investigation we evaluated 
suspected hepatic lesions using bo th  spin-echo 
M R I  on a 0.35 T superconduct ing  magne t  and 
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contras t -enhanced dynamic  incremental  computed  
t o m o g r a p h y  (CT) [8, 9]. The results of  this s tudy 
fo rm the basis of  our  report .  
Materials and Methods 
Thirty patients with known or suspected liver masses were stud- 
ied using both MRI and CT. The initial 9 were selected on 
the basis of a positive CT scan. The next 21 patients were pro- 
spectively examined by both techniques after being referred 
from the oncology service. In 17 of these patients, liver metas- 
tases were already pathologically proven and the exams were 
performed to evaluate tumor response to hepatic arterial che- 
motherapy. 
Magnetic resonance imaging was performed on a 0.35 T 
superconducting magnet (Diasonics Inc.) using nongated spin- 
echo imaging; details of the imager have been described pre- 
viously [10]. Multiple spin-echo pulse sequences (TR 0.5 or 
1.0 sec and either 1.5 or 2.0 sec, TE 28 and 56 msec) were ob- 
tained in all patients. Other TR or TE intervals are not select- 
able on this instrument. Respiratory gating was not used be- 
cause of technical difficulties in its routine implementation. 
Also, oral paramagnetic contrast was not used in this study. 
TI and T2 relaxation times were calculated from the intensity 
data [11] in the first 10 patients; they were not calculated in 
the 20 other patients because of difficulties in reliable quantifi- 
cation as previously reported [4, 5]. 
All CT scans were performed on 3rd generation scanners 
(General Electric CT/T 8800 or 9800) using the contrast-en- 
hanced dynamic incremental technique; 100ml meglumine 
iothalamate 60% (Conray| 60) was hand-injected as an intra- 
venous bolus immediately before scanning [8, 9]. Dilute oral 
contrast was administered before scanning to all patients. Scans 
were photographed at both soft tissue (width 500, level 30 HU) 
and liver (width 150, level 70 HU) windows prior to interpreta- 
tion. 
Both MRI and CT scans were independently reviewed at 
the time of the initial examination by the authors and dictated 
for the clinical record. All scans were evaluated retrospectively 
by the senior author. The scan data were then grouped into 
9 3 categories : Group I, MRI and CT equal in hepatic evalua- 
tion; Group II, MRI better than CT; Group III, CT better 
than MRI. To minimize subjective bias, a modality was consid- 
ered "better" than the other only when it detected disease oc- 
cult to the other modality, when numerous additional lesions 
were identified, or when extent of disease was much more 
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clearly defined. Evaluation of  the extrahepatic upper abdomen 
was also performed using similar categories. 
Results 
Of the 30 patients studied, 27 had focal liver ab- 
normalities; final diagnoses are listed in Table 1. 
Twenty-three patients (metastases in 17, hepato- 
mas 2, abscesses 3, regenerating nodule 1) had tis- 
sue proof of the final diagnosis, while in 7 patients 
the diagnosis was proven clinically. In 3 of these 
7 patients the liver was considered normal on the 
basis of  normal MRI and CT scans as well as clini- 
cal follow-up. In I patient with tissue-proved end- 
stage cirrhosis (without evidence for hepatoma), 
the visualized lesions (seen only on MRI) were as- 
sumed to represent regenerating nodules. One pa- 
tient with a large (9 cm) focal mass, assumed to 
be a primary liver tumor on the basis of  MRI, 
CT, and angiographic evaluation, declined surgery 
or biopsy. In another patient, a diagnosis of  he- 
patic infarction was established on the basis of  an- 
giography and compatible clinical findings. Final- 
Table 1. Final hepatic diagnosis 
Diagnosis Number 
Metastases 17" 
Primary liver tumor 3 
Abscess 3 
Normal 3 
Regenerating nodules 2 
Infarction 1 
Cyst 1 
aColon 9, carcinoid 3, pancreas 2, stomach 1, lung 1, breast 1. 
ly, 1 patient had no tissue proof of liver status 
because CT demonstrated a classic hepatic cyst. 
Of the 27 patients with focal lesions, initial scan 
interpretation of both modalities detected at least 
1 mass in 21 patients, whereas in 5 patients lesions 
were not detected by MRI (3 metastases, 1 infarct, 
1 regenerating nodule), and in 1 patient (the other 
patient with regenerating nodule) CT failed to 
identify a hepatic abnormality. When scans were 
retrospectively reviewed, both modalities detected 
at least I lesion in 26 patients, with MRI and CT 
each failing to identify a regenerating nodule in 
different patients. When MRI and CT scans were 
assigned to 1 of 3 groups as described, both modal- 
ities were equivalent in 15 patients (Fig. 1), CT was 
more informative in 11 patients (Figs. 2-4), and 
MRI was better in I patient (Fig. 5). 
The extrahepatic upper abdomen was normal 
in 25 patients and abnormal in 5 others. Magnetic 
resonance detected extrahepatic disease in 2 pa- 
tients (adrenal mass in I patient; adrenal mass, ret- 
roperitoneal adenopathy, and pulmonary nodules 
in another patient) whereas CT detected extrahe- 
patic abnormalities in 5 patients (identical findings 
to MRI in the 2 patients, plus gastric thickening 
due to carcinoma in 1 patient, splenic metastases 
in another patient, and anastomotic site colon car- 
cinoma recurrence in a final patient) (Fig. 6). 
The relative intensities of the liver lesions com- 
pared to normal hepatic parenchyma for the var- 
ious spin-echo MRI pulse sequences are presented 
in Table 2. As previously noted, many lesions were 
isointense at any 1 pulse sequence [4]; however, 
at the TR 1.5 or 2.0 sec, TE 28 and 56 msec se- 
quences only 1 lesion (regenerating nodule) was 
Fig. 1. Findings on CT and MRI studies of metastatic colon 
carcinoma. A Solitary hepatic metastasis evident on postcon- 
trast CT. B Magnetic resonance imaging (TR 2.0 sec, TE 
56 msec) demonstrates the metastasis as well as CT. 
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Fig. 2. Metastatic colon carcinoma. Extent of disease is better 
defined on CT. A Postcontrast  CT at plane of celiac axis shows 
innumerable focal metastases. B A t  same plane MRI (TR 
2.0 sec, TE 28 msec) demonstrates hyperintense lesions with less 
clarity. C At TR 2.0 sec, TE 56 msec (lesions even less well 
defined at TR 0.5 sec). Arrow indicates metastasis in lateral 
segment; left lobe poorly depicted on MRI.  
Fig. 3. Candida hepatic microabscesses in leukemic patient;  CT 
better defines the number  of lesions. A Multiple tiny, low- 
at tenuation hepatic lesions on CT. B Several lesions barely visi- 
ble at TR 1.0 sec, TE 28 msec. Note  lesion at posterior tip 
of right lobe (arrow). C On TR 1.0 see, TE 56 msec image, fewer 
lesions are visible than on CT and are difficult to distinguish 
from hepatic vein branches. 
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Fig. 4. Multifocal hepatoma with lesions in lateral segment of 
left lobe better defined by CT. A Postcontrast CT at plane of 
right portal vein shows multiple lesions in right and left hepatic 
lobes. B Corresponding MRI  (TR 1.5 sec, TE 56 msec) at same 
plane shows multiple lesions but fails to identify smaller foci 
of tumor in lateral segment of left lobe. 
Fig. 5. Alpha-l-antitrypsin deficiency with end-stage cirrhosis 
and presumed regenerating nodules. Lesions missed by CT are 
visible using MRI. A Computed tomographic scan shows cyst 
with calcified wall plus irregular liver contour, enlarged lateral 
segment of left lobe compatible with cirrhosis. Ascites visible 
at soft tissue window. B At TR 0.5 sec, TE 28 msec, high-inten- 
sity rounded lesions are present (arrowheads). Cyst (c) also not- 
ed posteriorly. A, ascites. 
Fig. 6. Recurrence of colon carcinoma at site of anastomosis. A Computed tomographic scan clearly shows soft tissue mass 
displacing opacified bowel from surgical clips. B Mass cannot be distinguished from normal bowel on corresponding MRI. 
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Fig. 7. Metastatic rectal carcinoma. A Two fairly homogeneous 
low-attenuation lesions are identified on contrast-enhanced CT. 
B At TR 2.0 sec, TE 56 msec, lesion architecture is much better 
shown by MRI. High-intensity center (possibly necrotic region) 
and rim are present in both lesions. 
Table 2. MRI appearance of liver lesions in 27 patients 
Lesion intensity relative TR 0.5 sec TR 0.5 sec TR 1.5 or 2.0 sec TR 1.5 or 2.0 sec 
to normal liver TE 28 msec TE 56 msec TE 28 msec TE 56 msec 
Diminished 12 8 4 2 
Isointense 14 15 7 6 
Increased 1 4 16 19 
isointense, whereas in 8 patients lesions were not 
detectable when a TR interval of  0.5 sec was used 
(3 patients with metastases, 2 hepatomas, 1 infarct, 
1 abscess, 1 regenerating nodule). No lesion was 
seen solely at TR 0.5 sec; however, internal archi- 
tecture and lesion extent were sometimes best de- 
fined at this pulse sequence. At a short TR interval 
(0.5 sec), lesions tended to be either hypointense 
or isointense, whereas the lesions were generally 
hyperintense at long TR intervals (1.5 or 2.0 sec). 
In some lesions equally well detected by both mo- 
dalities, internal architecture was significantly bet- 
ter defined with MRI than CT (Fig. 7). 
The calculated T1 and T2 relaxation times 
(10patients) were 378 (SD 164, range 295- 
811 msec) and 50 (SD 17, range 37-100 msec), re- 
spectively, in normal liver and 684 (SD 242, range 
238- 1100 msec) and 66 (SD 15, range 39-89 msec) 
in the liver lesions. 
Discussion 
Prior investigations have reported that MRI and 
CT are roughly comparable in detecting focal he- 
patic lesions [1, 2, 4]. These studies were relatively 
uncritical since only the presence or absence of 
disease was evaluated. Since hepatic lesions are of- 
ten large and multiple, differences between modali- 
ties are unlikely to be reflected solely by their abili- 
ty to detect disease. When we analyzed our data 
more critically, we found nongated spin-echo MRI 
using the commercially available pulse sequences 
noted inferior to contrast-enhanced dynamic CT 
in the evaluation of liver lesions. In this study, 
CT more clearly defined the hepatic lesions in 
11/27 (41%) patients. Furthermore, in 3/5 patients 
with significant extrahepatic disease, MRI missed 
abnormalities detectable using CT. 
Clear definition of the extent of  hepatic disease 
is important in 2 major instances. First, in patients 
with disease that may be treatable surgically (ab- 
scess, hepatoma, or other primary tumors sparing 
at least 1 hepatic segment) the precise distribution 
of disease is of  major importance and influences 
surgical management. Magnetic resonance imaging 
would have been misleading in planning surgical 
therapy in 3 of our patients; in 1 patient hepatoma 
involved all liver segments on CT examination but 
apparently spared the lateral segment of the left 
lobe on MRI. In 2 other patients the number of 
hepatic abscesses was underestimated using MRI. 
Secondly, in patients undergoing medical treat- 
ment such as hepatic arterial chemotherapy for 
liver metastases, the precise extent of  disease is ira- 
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portant  to establish so that effects of therapy can 
be monitored. Thus, al though MRI  and CT both 
detected presence or absence of hepatic disease 
with comparable accuracy in our series, the ability 
of CT to define more accurately the extent of dis- 
ease made it much more clinically efficacious. 
Many of the masses identified using CT but missed 
by MRI  were small, measuring less than 2 cm. It 
seems likely that  image blurring from respiratory 
motion significantly affected the ability to detect 
these small lesions [12]. Respiratory gating was not 
available to us at the time of this study; however, 
when implemented, it will likely improve lesion de- 
tection at the expense of significantly increased 
M R I  imaging time. 
In our study we only used spin-echo imaging; 
the average time of  M R I  examination was 1-t  1/2 
hours. Because of time constraints, we were un- 
able to use inversion-recovery sequences. This may 
have significantly biased our results. However, a 
recent investigation using identical MRI  equip- 
ment  reported equivalent hepatic lesion detectabil- 
ity using inversion-recovery pulse sequences and 
the same spin-echo pulse sequences we used [4]. 
Another  limitation to this study was the inability, 
due to equipment constraints, to obtain images at 
either very short TR or long TE intervals; the ef- 
fect of this limitation on lesion detectability is un- 
clear. Another  significant limitation relates to the 
fact that  we examined our patients on only 1 com- 
mercially available MRI  imager; thus our results 
may not accurately reflect the capabilities of MRI  
using different equipment. 
Although our results are somewhat pessimistic 
regarding the current clinical value of  nongated 
spin-echo MRI  using the pulse sequences reported 
in evaluating hepatic masses, they should be placed 
in proper perspective. Magnetic resonance imaging 
is relatively new and significant improvements in 
the technology are occurring rapidly. More specifi- 
cally, further refinements in equipment that im- 
prove signal-to-noise ratio, the development of 
combined cardiac and respiratory gating, addition- 
al pulse sequences (e.g., chemical shift imaging) 
[13], and intravenous (as well as oral) contrast 
agents [14] can be expected to improve significant- 
ly the accuracy of the method.  
Quantitat ion of the relaxation parameters, 
which is currently not useful, may also prove more 
valuable in the future when these measurements 
are less affected by biological mot ion and equip- 
ment artifacts [12]. The internal architecture of  a 
lesion is often better depicted by MRI  than CT, 
which raises the possibility of differentiating viable 
from necrotic tissue within a lesion. Finally, this 
study included a heterogeneous group of hepatic 
lesions and it is probable that at least a subset 
of such lesions will be equally or better defined 
using M R t  than by CT (e.g., hemangiomas) [15]. 
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